Bone Biologics BBLG
NASDAQ BBLG
$0.49 -0.01 (-1.30%)
As of: Sep 30, 2026 · 3:59 PM EDT

Bone Biologics (BBLG) Capital Expenditures (2015)

Updated

Bone Biologics (BBLG) recorded Capital Expenditures of $504.00 in FY2015, down 95.8% from $11,901 in FY2014.

Analysis

Bone Biologics (BBLG) Capital Expenditures (2015) Analysis & Trends

  • Per Business Quant data, BBLG's Capital Expenditures was $11,901 in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 450.00 Mn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 497.00 Mn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 269.00 Mn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 112.60 Mn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 503.00 Mn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 202.00 Mn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 195.00 Mn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 66.90 Mn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 143.00 Mn
10 Bone Biologics 905,190.00 905,190.00 - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 504.00
API Access

Bone Biologics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BBLG&period=max&api_key=YOUR_API_KEY